Ill health burden increases in Australia New statistics from the AIHW suggest that people spent more time unwell in 2022 than previous years – a trend driven by COVID-19.
Updated action plan for essential COPD management Dr Kerry Hancock gives an overview of the Lung Foundation’s updated COPD Action Plan to ensure best practice when self-managing exacerbations.
Rheumatic fever and heart disease Dhineli Perera chats to infectious diseases specialist Professor Anna Ralph about acute rheumatic fever and rheumatic heart disease. Who gets these conditions, how are they diagnosed, and how do we manage them?
Does nose picking lead to dementia? Researchers Dr Joyce Siette and Professor Mark Patrick Taylor analyse a recent study that has generated a lot of media interest.
Study identifies link between COVID-19 and Parkinson’s Researchers say the virus aggravates brain cells similar to neurodegenerative conditions, flagging potential future risk, but also treatments.
CT Coronary Calcium Scores In Cardiovascular Risk Assessment Dr Vance Manins, a cardiologist with a special interest in advanced cardiac failure and cardiac imaging, explains the difference between CT coronary calcium scores and CT coronary angiography.
Polycystic kidney disease Dhineli Perera chats to nephrologist Gopi Rangan about autosomal dominant polycystic kidney disease – simple interventions, drug treatment and pain management.
Upcoming MBS changes GPs need to know From 1 November, a number of MBS changes will be instituted that are likely to have some impact on general practice.
New clinical support for ‘silent but deadly’ disease Chronic kidney disease detection and management resources have been released, days after it was labelled a ‘national emergency’.
SGLT2 inhibitors for kidney and heart disease Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease.